• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病遗传学的多重模型。

The multiplex model of the genetics of Alzheimer's disease.

机构信息

Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.

UK Dementia Research Institute, School of Medicine, Cardiff University, Cardiff, UK.

出版信息

Nat Neurosci. 2020 Mar;23(3):311-322. doi: 10.1038/s41593-020-0599-5. Epub 2020 Feb 28.

DOI:10.1038/s41593-020-0599-5
PMID:32112059
Abstract

Genes play a strong role in Alzheimer's disease (AD), with late-onset AD showing heritability of 58-79% and early-onset AD showing over 90%. Genetic association provides a robust platform to build our understanding of the etiology of this complex disease. Over 50 loci are now implicated for AD, suggesting that AD is a disease of multiple components, as supported by pathway analyses (immunity, endocytosis, cholesterol transport, ubiquitination, amyloid-β and tau processing). Over 50% of late-onset AD heritability has been captured, allowing researchers to calculate the accumulation of AD genetic risk through polygenic risk scores. A polygenic risk score predicts disease with up to 90% accuracy and is an exciting tool in our research armory that could allow selection of those with high polygenic risk scores for clinical trials and precision medicine. It could also allow cellular modelling of the combined risk. Here we propose the multiplex model as a new perspective from which to understand AD. The multiplex model reflects the combination of some, or all, of these model components (genetic and environmental), in a tissue-specific manner, to trigger or sustain a disease cascade, which ultimately results in the cell and synaptic loss observed in AD.

摘要

基因在阿尔茨海默病(AD)中起着重要作用,迟发性 AD 的遗传率为 58-79%,早发性 AD 的遗传率超过 90%。遗传关联为我们深入了解这种复杂疾病的病因提供了一个强大的平台。现在已经有 50 多个基因座与 AD 相关,这表明 AD 是一种多成分的疾病,这一观点得到了通路分析(免疫、内吞作用、胆固醇转运、泛素化、淀粉样蛋白-β 和 tau 处理)的支持。超过 50%的迟发性 AD 遗传率已经被捕获,这使得研究人员能够通过多基因风险评分计算 AD 遗传风险的积累。多基因风险评分的疾病预测准确率高达 90%,这是我们研究武器库中的一个令人兴奋的工具,它可以让我们选择那些具有高多基因风险评分的人进行临床试验和精准医学。它还可以允许对组合风险进行细胞建模。在这里,我们提出了多重模型,作为一种新的视角来理解 AD。多重模型以组织特异性的方式反映了某些或所有这些模型成分(遗传和环境)的组合,以引发或维持疾病级联反应,最终导致 AD 中观察到的细胞和突触丢失。

相似文献

1
The multiplex model of the genetics of Alzheimer's disease.阿尔茨海默病遗传学的多重模型。
Nat Neurosci. 2020 Mar;23(3):311-322. doi: 10.1038/s41593-020-0599-5. Epub 2020 Feb 28.
2
From Polygenic Scores to Precision Medicine in Alzheimer's Disease: A Systematic Review.从多基因评分到阿尔茨海默病的精准医学:一项系统综述。
J Alzheimers Dis. 2020;74(4):1271-1283. doi: 10.3233/JAD-191233.
3
The Differential Influence of Immune, Endocytotic, and Lipid Metabolism Genes on Amyloid Deposition and Neurodegeneration in Subjects at Risk of Alzheimer's Disease.免疫、内吞和脂质代谢基因对阿尔茨海默病风险人群中淀粉样蛋白沉积和神经退行性变的差异影响。
J Alzheimers Dis. 2021;79(1):127-139. doi: 10.3233/JAD-200578.
4
The new genetic landscape of Alzheimer's disease: from amyloid cascade to genetically driven synaptic failure hypothesis?阿尔茨海默病的新遗传图谱:从淀粉样蛋白级联到基因驱动的突触故障假说?
Acta Neuropathol. 2019 Aug;138(2):221-236. doi: 10.1007/s00401-019-02004-0. Epub 2019 Apr 13.
5
Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss.阿尔茨海默病风险因素 Pyk2 介导淀粉样β诱导的突触功能障碍和丧失。
J Neurosci. 2019 Jan 23;39(4):758-772. doi: 10.1523/JNEUROSCI.1873-18.2018. Epub 2018 Dec 5.
6
Association between polygenic risk score of Alzheimer's disease and plasma phosphorylated tau in individuals from the Alzheimer's Disease Neuroimaging Initiative.阿尔茨海默病神经影像学倡议中个体的阿尔茨海默病多基因风险评分与血浆磷酸化 tau 的关系。
Alzheimers Res Ther. 2021 Jan 8;13(1):17. doi: 10.1186/s13195-020-00754-8.
7
Effects of Alzheimer's disease-associated risk loci on cerebrospinal fluid biomarkers and disease progression: a polygenic risk score approach.阿尔茨海默病相关风险基因座对脑脊液生物标志物及疾病进展的影响:一种多基因风险评分方法
J Alzheimers Dis. 2015;43(2):565-73. doi: 10.3233/JAD-140777.
8
Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset forms.散发性晚发性阿尔茨海默病的多基因风险评分揭示了与家族性和早发性形式的共同结构。
Alzheimers Dement. 2018 Feb;14(2):205-214. doi: 10.1016/j.jalz.2017.08.013. Epub 2017 Sep 21.
9
Clinical genetics of Alzheimer's disease.阿尔茨海默病的临床遗传学
Biomed Res Int. 2014;2014:291862. doi: 10.1155/2014/291862. Epub 2014 May 13.
10
Genetic variants in glutamate-, Aβ-, and tau-related pathways determine polygenic risk for Alzheimer's disease.谷氨酸能、Aβ 和 tau 相关通路中的遗传变异决定了阿尔茨海默病的多基因风险。
Neurobiol Aging. 2021 May;101:299.e13-299.e21. doi: 10.1016/j.neurobiolaging.2020.11.009. Epub 2020 Nov 12.

引用本文的文献

1
Bone marrow B lymphopoiesis accelerates early cerebral amyloid pathology.骨髓B淋巴细胞生成加速早期脑淀粉样病变。
Signal Transduct Target Ther. 2025 Sep 18;10(1):312. doi: 10.1038/s41392-025-02419-0.
2
Understanding the genetics and neurology: an overview of adult neurogenetics.理解遗传学与神经学:成人神经遗传学概述
Asian Biomed (Res Rev News). 2025 Sep 2;19(4):196-208. doi: 10.2478/abm-2025-0022. eCollection 2025 Aug.
3
MS4A6A/Ms4a6d deficiency disrupts neuroprotective microglia functions and promotes inflammation in Alzheimer's disease model.

本文引用的文献

1
Genetic variability in response to amyloid beta deposition influences Alzheimer's disease risk.对β-淀粉样蛋白沉积反应的基因变异性影响阿尔茨海默病风险。
Brain Commun. 2019;1(1):fcz022. doi: 10.1093/braincomms/fcz022. Epub 2019 Oct 10.
2
Genetic architecture of subcortical brain structures in 38,851 individuals.38851 个人的皮质下脑结构的遗传结构。
Nat Genet. 2019 Nov;51(11):1624-1636. doi: 10.1038/s41588-019-0511-y. Epub 2019 Oct 21.
3
Inferring the Molecular Mechanisms of Noncoding Alzheimer's Disease-Associated Genetic Variants.
MS4A6A/Ms4a6d基因缺陷破坏了具有神经保护作用的小胶质细胞功能,并在阿尔茨海默病模型中促进炎症反应。
Mol Neurodegener. 2025 Aug 28;20(1):94. doi: 10.1186/s13024-025-00887-0.
4
Integrative machine learning approach to risk prediction for dementia and Alzheimer's disease.用于痴呆症和阿尔茨海默病风险预测的综合机器学习方法。
Geroscience. 2025 Aug 27. doi: 10.1007/s11357-025-01828-x.
5
Recruitment and Retention for Alzheimer's Disease Diversity Genetic Cohorts in the ADSP (READD-ADSP): A global effort to identify genetic factors in Alzheimer's disease.阿尔茨海默病药物研发计划(ADSP)中阿尔茨海默病多样性遗传队列的招募与保留(READD - ADSP):一项识别阿尔茨海默病遗传因素的全球行动。
Alzheimers Dement (N Y). 2025 Aug 25;11(3):e70148. doi: 10.1002/trc2.70148. eCollection 2025 Jul-Sep.
6
miR-361-5p contributes to the pathogenesis of Alzheimer's disease.微小RNA-361-5p促成阿尔茨海默病的发病机制。
Sci Rep. 2025 Aug 23;15(1):31046. doi: 10.1038/s41598-025-17112-z.
7
Leveraging functional annotations to map rare variants associated with Alzheimer disease with gruyere.利用功能注释通过格鲁耶尔奶酪法来映射与阿尔茨海默病相关的罕见变异。 (注:“gruyere”可能是特定方法名称,直接音译为“格鲁耶尔”,具体含义可能需结合专业背景理解)
Am J Hum Genet. 2025 Aug 13. doi: 10.1016/j.ajhg.2025.07.016.
8
Psychedelics meet human brain organoids: insights into proteomics and potential for Alzheimer's disease treatment.迷幻剂与人类脑类器官:蛋白质组学见解及阿尔茨海默病治疗潜力
Front Dement. 2025 Aug 4;4:1605051. doi: 10.3389/frdem.2025.1605051. eCollection 2025.
9
An exploration of testing genetic associations using goodness-of-fit statistics based on deep ReLU neural networks.基于深度ReLU神经网络,使用拟合优度统计量探索基因关联检测。
Front Syst Biol. 2024 Nov 18;4:1460369. doi: 10.3389/fsysb.2024.1460369. eCollection 2024.
10
Immunosenescence: signaling pathways, diseases and therapeutic targets.免疫衰老:信号通路、疾病与治疗靶点。
Signal Transduct Target Ther. 2025 Aug 6;10(1):250. doi: 10.1038/s41392-025-02371-z.
推断非编码阿尔茨海默病相关遗传变异的分子机制。
J Alzheimers Dis. 2019;72(1):301-318. doi: 10.3233/JAD-190568.
4
Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer's disease.基于基因的分析在 HRC 导入基因组全基因组关联数据中确定了三个新的阿尔茨海默病基因。
PLoS One. 2019 Jul 8;14(7):e0218111. doi: 10.1371/journal.pone.0218111. eCollection 2019.
5
Trans Effects on Gene Expression Can Drive Omnigenic Inheritance.转录效应对基因表达的影响可驱动全基因组遗传。
Cell. 2019 May 2;177(4):1022-1034.e6. doi: 10.1016/j.cell.2019.04.014.
6
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.基于诊断的阿尔茨海默病的全基因组关联荟萃分析鉴定出新的风险位点,并提示 Aβ、tau、免疫和脂类代谢过程的作用。
Nat Genet. 2019 Mar;51(3):414-430. doi: 10.1038/s41588-019-0358-2. Epub 2019 Feb 28.
7
Microglia - mediated immunity partly contributes to the genetic association between Alzheimer's disease and hippocampal volume.小胶质细胞介导的免疫反应部分导致了阿尔茨海默病和海马体体积之间的遗传关联。
Brain Behav Immun. 2019 Jul;79:267-273. doi: 10.1016/j.bbi.2019.02.011. Epub 2019 Feb 15.
8
Alzheimer's disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph.阿尔茨海默病磷脂酶 C-γ-2 (PLCG2) 保护性变体是一种功能超变体。
Alzheimers Res Ther. 2019 Feb 2;11(1):16. doi: 10.1186/s13195-019-0469-0.
9
Polygenic impact of common genetic risk loci for Alzheimer's disease on cerebral blood flow in young individuals.常见阿尔茨海默病遗传风险位点对年轻人脑血流的多基因影响。
Sci Rep. 2019 Jan 24;9(1):467. doi: 10.1038/s41598-018-36820-3.
10
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.全基因组荟萃分析确定了新的位点和功能途径,影响阿尔茨海默病的风险。
Nat Genet. 2019 Mar;51(3):404-413. doi: 10.1038/s41588-018-0311-9. Epub 2019 Jan 7.